Holen Sie sich die Stockscreener-App
10.42
1.18%
-0.1341
Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
7.00
|
- | 0.677 | 7.679 | - |
| Operating Expenses |
15.87%
67.63
|
80.39 | 77.52 | 92.55 | 84.98 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
15.87%
67.63
|
80.39 | 77.52 | 92.55 | 84.98 |
| Operating Income/Loss |
24.58%
-60.63
|
-80.39 | -76.85 | -84.87 | -84.98 |
| Income/Loss From Continuing Operations Before Tax |
109.44%
7.00
|
-74.15 | -70.38 | -77.06 | - |
| Income/Loss From Continuing Operations After Tax |
25.97%
-54.89
|
-74.15 | -70.38 | -77.06 | -76.00 |
Net Income/Loss
|
25.97%
-54.89
|
-74.15 | -70.38 | -77.06 | -76.00 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.64%
0.6127
|
172.39 | 171.26 | 169.23 | 8.2161 |
| Basic Earnings Per Share |
27.91%
-0.31
|
-0.43 | -0.41 | -0.46 | -0.42 |
| Diluted Earnings Per Share |
27.91%
-0.31
|
-0.43 | -0.41 | -0.46 | -0.42 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):